In 3 trials of sodium zirconium cyclosilicate, serum bicarbonate increased regardless of CKD stage. In addition to its potassium-binding ability, sodium zirconium cyclosilicate (SZC) may also increase ...
An oral potassium binder taken daily can enable the safe use of mineralocorticoid receptor antagonists (MRAs) in patients with heart failure with reduced ejection fraction (HFrEF) who are at risk for ...
Please provide your email address to receive an email when new articles are posted on . A potassium binder enabled more patients with heart failure to stay on ...
Edema: Each 5-g dose of LOKELMA contains approximately 400 mg of sodium, but the extent of absorption by the patient is unknown. In clinical trials of LOKELMA in patients who were not on dialysis, ...
This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Nihar R. Desai, MD ...
Chronic kidney disease (CKD) is a progressive loss of renal function over time, often leading to a diminished capacity to excrete acid and maintain electrolyte balance. This complex condition is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results